Magnesium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulphate ## Overview Magnesium sulphate is an essential mineral that plays a crucial role in various physiological processes, including muscle and nerve function, blood glucose control, and blood pressure regulation. It is available in oral and intravenous formulations. ## Primary Indications * **Hypomagnesemia:** Treatment and prevention of low magnesium levels. * **Eclampsia and Preeclampsia:** Management of severe preeclampsia and eclamptic seizures. * **Torsades de Pointes:** Treatment of a specific type of ventricular tachycardia. * **Constipation (Oral):** Short-term treatment of occasional constipation. * **Bronchodilation (Nebulized):** Adjunctive treatment for severe asthma exacerbations. ## Adult Dosing * **Hypomagnesemia:** * **Intravenous:** Typically 4-6 grams IV initially, followed by a maintenance infusion of 1-2 grams per hour, adjusted based on serum magnesium levels and clinical response. Usual maintenance is 16-40 mEq (80-200 mmol) per 24 hours. Higher doses may be required in severe deficiency. * **Intramuscular:** 1-4 grams IM every 4-6 hours as needed. * **Eclampsia/Preeclampsia:** * **Loading Dose:** 4-6 grams IV over 5-20 minutes. * **Maintenance Infusion:** 1-2 grams per hour IV. Dosing may vary per institutional protocol. * **Torsades de Pointes:** 1-2 grams IV in 10 mL of D5W over 5-10 minutes, followed by an infusion of 0.5-1 gram per hour. * **Constipation (Oral):** 25-30 grams of a saturated solution of magnesium citrate (e.g., 10 oz bottle) as a single dose. Magnesium sulphate oral solutions are also available, typically 2-4 tablespoons (30-60 mL) of a 10% solution. * **Bronchodilation (Nebulized):** 2 grams in 250 mL NS nebulized over 15-20 minutes. ## Pediatric Dosing * **Hypomagnesemia:** * **Intravenous:** 25-50 mg/kg/dose (0.1-0.2 mEq/kg/dose) IV over 10-20 minutes, may be repeated every 4-12 hours. For continuous infusion, 100-200 mg/kg/day (0.4-0.8 mEq/kg/day) divided every 6-8 hours or as a continuous infusion. Maximum single dose generally not to exceed 2 grams. Dosing is highly individualized based on magnesium levels and clinical status. * **Eclampsia/Preeclampsia:** Dosing typically follows adult protocols, but may be adjusted based on weight and renal function; consult pediatric specialist. * **Torsades de Pointes:** 25-50 mg/kg IV over 10 minutes, maximum 2 grams. * **Constipation (Oral):** Oral magnesium preparations are generally not recommended for pediatric use without specific guidance due to risk of electrolyte imbalance and dehydration. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with impaired renal function. Reduce dose and monitor serum magnesium levels closely. In severe renal impairment, administration may be contraindicated. ## Contraindications * Hypermagnesemia. * Myocardial (heart muscle) damage. * Heart block. * Intestinal obstruction or perforation (for oral formulations). * Rectal bleeding or undiagnosed abdominal pain (for oral formulations). ## Adverse Effects * **Common:** Flushing, sweating, hypotension, somnolence, hyporeflexia, nausea, vomiting. * **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, hypermagnesemia (symptoms include absent deep tendon reflexes, hypotension, ECG changes, respiratory depression, coma, cardiac arrest). ## Key Drug Interactions * **Neuromuscular Blockers:** Magnesium can potentiate neuromuscular blockade, leading to prolonged respiratory depression. Monitor closely. * **Calcium Channel Blockers:** Increased risk of hypotension and bradycardia. * **Tetracyclines and Quinolones:** Oral magnesium can decrease the absorption of these antibiotics. Separate administration by at least 2-4 hours. * **Bisphosphonates:** Oral magnesium can decrease the absorption of bisphosphonates. Separate administration by at least 2 hours. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with IV administration, to guide dosing and prevent toxicity. Target levels depend on indication. * **Renal Function:** Monitor BUN and creatinine. * **Deep Tendon Reflexes:** Assess for hyporeflexia, an early sign of hypermagnesemia. * **Respiratory Rate and Effort:** Monitor for signs of respiratory depression. * **Blood Pressure and Heart Rate:** Monitor for hypotension and bradycardia. * **Urine Output:** Adequate renal function is crucial for magnesium excretion. ## Clinical Pearls * Magnesium sulphate is an effective anticonvulsant for eclampsia and preeclampsia. * When administering IV magnesium, ensure calcium gluconate is readily available as an antidote for magnesium toxicity. * Oral magnesium laxatives should be used for short-term relief only. * Rapid IV infusion can cause flushing and hypotension. * In patients with renal impairment, careful monitoring is paramount. *** *This information is intended for healthcare professionals. Always verify current prescribing information and consult with a pharmacist or physician for individualized patient care.*